Compound Paracetamol and Amantadine Hydrochloride Tablet is an agent with antipyretic and analgesic effects. It can be used to treat nasal congestion, sore throat, headache, fever, etc. caused by colds. And it has preventive and therapeutic effects on influenza. The main ingredients are acetaminophen, amantadine hydrochloride, chlorpheniramine maleate, artificial bezoar, and caffeine. The auxiliary materials are starch, powdered sugar and magnesium stearate.
The global Compound Paracetamol and Amantadine Hydrochloride Tablets market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
The “Compound Paracetamol and Amantadine Hydrochloride Tablets Industry Forecast” looks at past sales and reviews total world Compound Paracetamol and Amantadine Hydrochloride Tablets sales in 2023, providing a comprehensive analysis by region and market sector of projected Compound Paracetamol and Amantadine Hydrochloride Tablets sales for 2024 through 2030. With Compound Paracetamol and Amantadine Hydrochloride Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Compound Paracetamol and Amantadine Hydrochloride Tablets industry.
This Insight Report provides a comprehensive analysis of the global Compound Paracetamol and Amantadine Hydrochloride Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Compound Paracetamol and Amantadine Hydrochloride Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Compound Paracetamol and Amantadine Hydrochloride Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Compound Paracetamol and Amantadine Hydrochloride Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Compound Paracetamol and Amantadine Hydrochloride Tablets.
United States market for Compound Paracetamol and Amantadine Hydrochloride Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Compound Paracetamol and Amantadine Hydrochloride Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Compound Paracetamol and Amantadine Hydrochloride Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Compound Paracetamol and Amantadine Hydrochloride Tablets players cover Sichuan YIKE Pharmaceutical Co., Ltd., Jilin Yida Pharmaceutical Co., Ltd., CSPC Pharmaceutical Group Limited, Inner Mongolia Beiyu Pharmaceutical Co., Ltd. and Zhejiang Shapuaisi Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Compound Paracetamol and Amantadine Hydrochloride Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Pediatric Compound Paracetamol and Amantadine Hydrochloride Tablets
Adult Compound Paracetamol and Amantadine Hydrochloride Tablets
Segmentation by application
Hospital
Clinic
Online Sales
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sichuan YIKE Pharmaceutical Co., Ltd.
Jilin Yida Pharmaceutical Co., Ltd.
CSPC Pharmaceutical Group Limited
Inner Mongolia Beiyu Pharmaceutical Co., Ltd.
Zhejiang Shapuaisi Pharmaceutical Co., Ltd.
Sunflower Pharmaceutical Group Co., Ltd.
Jilin Wutaigankang Pharmaceutical Co., Ltd.
Anhui Wansen Pharmaceutical Co., Ltd.
Jilin Jian Yisheng Pharmaceutical Co., Ltd.
Jilin Forte Pharmaceutical Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Compound Paracetamol and Amantadine Hydrochloride Tablets market?
What factors are driving Compound Paracetamol and Amantadine Hydrochloride Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Compound Paracetamol and Amantadine Hydrochloride Tablets market opportunities vary by end market size?
How does Compound Paracetamol and Amantadine Hydrochloride Tablets break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Compound Paracetamol and Amantadine Hydrochloride Tablets by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Compound Paracetamol and Amantadine Hydrochloride Tablets by Country/Region, 2019, 2023 & 2030
2.2 Compound Paracetamol and Amantadine Hydrochloride Tablets Segment by Type
2.2.1 Pediatric Compound Paracetamol and Amantadine Hydrochloride Tablets
2.2.2 Adult Compound Paracetamol and Amantadine Hydrochloride Tablets
2.3 Compound Paracetamol and Amantadine Hydrochloride Tablets Sales by Type
2.3.1 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Market Share by Type (2019-2024)
2.3.2 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Revenue and Market Share by Type (2019-2024)
2.3.3 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Sale Price by Type (2019-2024)
2.4 Compound Paracetamol and Amantadine Hydrochloride Tablets Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Online Sales
2.4.4 Others
2.5 Compound Paracetamol and Amantadine Hydrochloride Tablets Sales by Application
2.5.1 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Sale Market Share by Application (2019-2024)
2.5.2 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Revenue and Market Share by Application (2019-2024)
2.5.3 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Sale Price by Application (2019-2024)
3 Global Compound Paracetamol and Amantadine Hydrochloride Tablets by Company
3.1 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Breakdown Data by Company
3.1.1 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Annual Sales by Company (2019-2024)
3.1.2 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Market Share by Company (2019-2024)
3.2 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Annual Revenue by Company (2019-2024)
3.2.1 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Revenue by Company (2019-2024)
3.2.2 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Revenue Market Share by Company (2019-2024)
3.3 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Sale Price by Company
3.4 Key Manufacturers Compound Paracetamol and Amantadine Hydrochloride Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Compound Paracetamol and Amantadine Hydrochloride Tablets Product Location Distribution
3.4.2 Players Compound Paracetamol and Amantadine Hydrochloride Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Compound Paracetamol and Amantadine Hydrochloride Tablets by Geographic Region
4.1 World Historic Compound Paracetamol and Amantadine Hydrochloride Tablets Market Size by Geographic Region (2019-2024)
4.1.1 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Compound Paracetamol and Amantadine Hydrochloride Tablets Market Size by Country/Region (2019-2024)
4.2.1 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Annual Sales by Country/Region (2019-2024)
4.2.2 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Annual Revenue by Country/Region (2019-2024)
4.3 Americas Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Growth
4.4 APAC Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Growth
4.5 Europe Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Growth
4.6 Middle East & Africa Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Growth
5 Americas
5.1 Americas Compound Paracetamol and Amantadine Hydrochloride Tablets Sales by Country
5.1.1 Americas Compound Paracetamol and Amantadine Hydrochloride Tablets Sales by Country (2019-2024)
5.1.2 Americas Compound Paracetamol and Amantadine Hydrochloride Tablets Revenue by Country (2019-2024)
5.2 Americas Compound Paracetamol and Amantadine Hydrochloride Tablets Sales by Type
5.3 Americas Compound Paracetamol and Amantadine Hydrochloride Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Compound Paracetamol and Amantadine Hydrochloride Tablets Sales by Region
6.1.1 APAC Compound Paracetamol and Amantadine Hydrochloride Tablets Sales by Region (2019-2024)
6.1.2 APAC Compound Paracetamol and Amantadine Hydrochloride Tablets Revenue by Region (2019-2024)
6.2 APAC Compound Paracetamol and Amantadine Hydrochloride Tablets Sales by Type
6.3 APAC Compound Paracetamol and Amantadine Hydrochloride Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Compound Paracetamol and Amantadine Hydrochloride Tablets by Country
7.1.1 Europe Compound Paracetamol and Amantadine Hydrochloride Tablets Sales by Country (2019-2024)
7.1.2 Europe Compound Paracetamol and Amantadine Hydrochloride Tablets Revenue by Country (2019-2024)
7.2 Europe Compound Paracetamol and Amantadine Hydrochloride Tablets Sales by Type
7.3 Europe Compound Paracetamol and Amantadine Hydrochloride Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Compound Paracetamol and Amantadine Hydrochloride Tablets by Country
8.1.1 Middle East & Africa Compound Paracetamol and Amantadine Hydrochloride Tablets Sales by Country (2019-2024)
8.1.2 Middle East & Africa Compound Paracetamol and Amantadine Hydrochloride Tablets Revenue by Country (2019-2024)
8.2 Middle East & Africa Compound Paracetamol and Amantadine Hydrochloride Tablets Sales by Type
8.3 Middle East & Africa Compound Paracetamol and Amantadine Hydrochloride Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Compound Paracetamol and Amantadine Hydrochloride Tablets
10.3 Manufacturing Process Analysis of Compound Paracetamol and Amantadine Hydrochloride Tablets
10.4 Industry Chain Structure of Compound Paracetamol and Amantadine Hydrochloride Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Compound Paracetamol and Amantadine Hydrochloride Tablets Distributors
11.3 Compound Paracetamol and Amantadine Hydrochloride Tablets Customer
12 World Forecast Review for Compound Paracetamol and Amantadine Hydrochloride Tablets by Geographic Region
12.1 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Market Size Forecast by Region
12.1.1 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Forecast by Region (2025-2030)
12.1.2 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Forecast by Type
12.7 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Forecast by Application
13 Key Players Analysis
13.1 Sichuan YIKE Pharmaceutical Co., Ltd.
13.1.1 Sichuan YIKE Pharmaceutical Co., Ltd. Company Information
13.1.2 Sichuan YIKE Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Product Portfolios and Specifications
13.1.3 Sichuan YIKE Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sichuan YIKE Pharmaceutical Co., Ltd. Main Business Overview
13.1.5 Sichuan YIKE Pharmaceutical Co., Ltd. Latest Developments
13.2 Jilin Yida Pharmaceutical Co., Ltd.
13.2.1 Jilin Yida Pharmaceutical Co., Ltd. Company Information
13.2.2 Jilin Yida Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Product Portfolios and Specifications
13.2.3 Jilin Yida Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Jilin Yida Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Jilin Yida Pharmaceutical Co., Ltd. Latest Developments
13.3 CSPC Pharmaceutical Group Limited
13.3.1 CSPC Pharmaceutical Group Limited Company Information
13.3.2 CSPC Pharmaceutical Group Limited Compound Paracetamol and Amantadine Hydrochloride Tablets Product Portfolios and Specifications
13.3.3 CSPC Pharmaceutical Group Limited Compound Paracetamol and Amantadine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 CSPC Pharmaceutical Group Limited Main Business Overview
13.3.5 CSPC Pharmaceutical Group Limited Latest Developments
13.4 Inner Mongolia Beiyu Pharmaceutical Co., Ltd.
13.4.1 Inner Mongolia Beiyu Pharmaceutical Co., Ltd. Company Information
13.4.2 Inner Mongolia Beiyu Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Product Portfolios and Specifications
13.4.3 Inner Mongolia Beiyu Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Inner Mongolia Beiyu Pharmaceutical Co., Ltd. Main Business Overview
13.4.5 Inner Mongolia Beiyu Pharmaceutical Co., Ltd. Latest Developments
13.5 Zhejiang Shapuaisi Pharmaceutical Co., Ltd.
13.5.1 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Company Information
13.5.2 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Product Portfolios and Specifications
13.5.3 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Latest Developments
13.6 Sunflower Pharmaceutical Group Co., Ltd.
13.6.1 Sunflower Pharmaceutical Group Co., Ltd. Company Information
13.6.2 Sunflower Pharmaceutical Group Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Product Portfolios and Specifications
13.6.3 Sunflower Pharmaceutical Group Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Sunflower Pharmaceutical Group Co., Ltd. Main Business Overview
13.6.5 Sunflower Pharmaceutical Group Co., Ltd. Latest Developments
13.7 Jilin Wutaigankang Pharmaceutical Co., Ltd.
13.7.1 Jilin Wutaigankang Pharmaceutical Co., Ltd. Company Information
13.7.2 Jilin Wutaigankang Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Product Portfolios and Specifications
13.7.3 Jilin Wutaigankang Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Jilin Wutaigankang Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 Jilin Wutaigankang Pharmaceutical Co., Ltd. Latest Developments
13.8 Anhui Wansen Pharmaceutical Co., Ltd.
13.8.1 Anhui Wansen Pharmaceutical Co., Ltd. Company Information
13.8.2 Anhui Wansen Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Product Portfolios and Specifications
13.8.3 Anhui Wansen Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Anhui Wansen Pharmaceutical Co., Ltd. Main Business Overview
13.8.5 Anhui Wansen Pharmaceutical Co., Ltd. Latest Developments
13.9 Jilin Jian Yisheng Pharmaceutical Co., Ltd.
13.9.1 Jilin Jian Yisheng Pharmaceutical Co., Ltd. Company Information
13.9.2 Jilin Jian Yisheng Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Product Portfolios and Specifications
13.9.3 Jilin Jian Yisheng Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Jilin Jian Yisheng Pharmaceutical Co., Ltd. Main Business Overview
13.9.5 Jilin Jian Yisheng Pharmaceutical Co., Ltd. Latest Developments
13.10 Jilin Forte Pharmaceutical Co., Ltd.
13.10.1 Jilin Forte Pharmaceutical Co., Ltd. Company Information
13.10.2 Jilin Forte Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Product Portfolios and Specifications
13.10.3 Jilin Forte Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Jilin Forte Pharmaceutical Co., Ltd. Main Business Overview
13.10.5 Jilin Forte Pharmaceutical Co., Ltd. Latest Developments
14 Research Findings and Conclusion
*If Applicable.